Blockade of ANG II type 1A receptor (AT 1A) is known to attenuate postinfarction [postmyocardial infarction (post-MI)] heart failure, accompanying reduction in fibrosis of the noninfarcted area. In the present study, we investigated the influence of AT 1A blockade on the infarcted tissue itself. Consistent with earlier reports, AT1A knockout (AT1AKO) mice showed significantly attenuated left ventricular (LV) remodeling (dilatation) and dysfunction compared with wild-type (WT) mice. Morphometry revealed that the infarcted wall was thicker and had a smaller circumferential length in AT 1AKO than WT hearts. In addition, significantly greater numbers of cells were present within infarcts in AT 1AKO hearts 4 wk post-MI; most notably, there was an abundance of vessels and myofibroblasts. One week post-MI, the incidence of apoptosis among granulation tissue cells was fewer (3.3 Ϯ 0.4 vs. 4.4 Ϯ 0.5% in WT, P Ͻ 0.05), whereas vessel proliferation was higher in AT 1AKO hearts, which likely explains the later abundance of cells within the scar tissue. Insulin-like growth factor receptor-I was upregulated and its downstream signal protein kinase B (Akt) was significantly activated in infarcted AT 1AKO hearts compared with WT hearts. Inactivation of Akt with wortmannin partially but significantly prevented the benefits observed in AT 1AKO. Collectively, in AT1AKO hearts, Akt-mediated granulation tissue cell proliferation and preservation resulting from antiapoptosis likely contributed to an abundant cell population that altered the infarct scar structure, thereby reducing wall stress and attenuating LV dilatation and dysfunction at the chronic stage. In conclusion, altered structural dynamics of infarct scar and increasing myocardial fibrosis may be responsible for the deleterious effects of AT 1A signaling following MI.
EVIDENCE BASED ON EXPERIMENTS using angiotensin-converting enzyme (ACE) inhibitors, ANG II type 1 receptor (AT 1 ) blockers, and genetically engineered animals lacking ANG II type 1A receptor (AT 1A ) has shown that AT 1 signaling is a critical mediator of the progression of postmyocardial infarction (post-MI) left ventricular (LV) remodeling and heart failure (12, 26, 29) . Local renin-angiotensin system is known to be activated in infarcted tissue of the heart; de novo production of angiotensinogen, renin, ACE, and ANG II in cardiac myocytes or fibroblasts significantly influence the postinfarction remodeling of the heart (15, 36) . In that regard, myocardial fibrosis within noninfarcted tissue, which increases myocardial stiffness, is known to be diminished by AT 1 blockade, perhaps resulting in improved cardiac performance (12) . However, it is questionable whether the reduced fibrosis within the noninfarcted area alone can explain such a significant improvement of cardiac function. For example, the percent fibrosis area was ϳ1% in genetically engineered mice lacking AT 1A (AT 1A knockout mice, AT 1A KO), whereas that was ϳ3% in the wild-type mice (WT); the percentages are relatively small (12) . An infarcted tissue is highly dynamic and shows remarkable changes during the course of healing: necrotic tissue is infiltrated by inflammatory cells during the acute stage of MI; granulation tissue forms during the subacute stage; and scar tissue forms during the chronic stage (30, 33, 39) . Although the magnitude of the acute MI, which can be determined within several hours of an attack (24) , is the most critical determinant of subsequent heart failure, many other factors, including late death or hypertrophy of cardiomyocytes, fibrosis, and the expression of various cytokines, are also associated with disease progression (3, 19, 27, 37) . However, little is known about the effects of AT 1A signaling on the infarct itself.
We hypothesized that AT 1A signaling affects the structural dynamics of infarcted tissue, thereby providing a significant influence on the postinfarction disease process. To test that hypothesis, we first performed a detailed morphological analysis of AT 1A -mediated alterations of post-MI hearts using AT 1A KO and then determined the pathophysiological and molecular mechanisms for the observed effects.
MATERIALS AND METHODS

Experimental MI in Mice
This study was approved by our Institutional Animal Research Committee. Twelve-week-old male AT1AKO and WT mice from C57BL/6 background were used in this study (28) . The AT1AKO mice were a gift from Tanabe Pharmaceutical (Tokyo, Japan); the WT mice (C57BL/6) were purchased from Chubu-Kagaku (Nagoya, Japan). MI was induced by permanently ligating the left coronary artery as previously described (17) . In sham-operated mice, the suture was passed but not tied. Animals were subsequently killed 2 days, 1 wk, or 4 wk after surgery. Animals killed 1 wk post-MI were intraperito-neally administered bromodeoxyuridine (BrdU) at the dose of 50 mg ⅐ kg Ϫ1 ⅐ day Ϫ1 for 3 days before death to assess cell proliferation.
Hydralazine Treatment
Hydralazine (Sigma) was administered to WT mice to examine the effect of blood pressure on infarct tissue dynamics because systolic blood pressure was reportedly lower in AT1AKO mice than WT mice (28) . The treatment was performed by the method previously described (32) . According to our preliminary experiments, hydralazine at the dose of 15 mg ⅐ kg Ϫ1 ⅐ day Ϫ1 brought about low blood pressure in WT mice similar to AT1AKO mice.
Inhibition of Akt Signaling
To shed light on molecular biological mechanisms for AT1A effects on infarct tissue, Akt signaling was inhibited in mice with MI. Wortmannin (Sigma), a widely used phosphatidylinositol 3-kinase (PI 3-kinase)/protein kinase B (Akt) inhibitor, was intraperitoneally injected at the dose of 17 g ⅐ kg Ϫ1 ⅐ day Ϫ1 , beginning on the 3rd day of MI and continuing until death.
Physiological Studies
Echocardiograms were recorded using an echocardiographic system (Aloka) equipped with a 7.5-MHz imaging transducer 4 wk post-MI (17) . Thereafter, the right carotid artery was cannulated with a micromanometer-tipped catheter (SPR 671; Millar Instruments) that was advanced in the aorta and then in the LV to record pressures and determine ϮdP/dt (17) .
Histology
Once the physological measurements were complete, all surviving mice were killed, and the hearts were removed and cut into two transverse slices at midventricle, between the atrioventricular groove and the apex. The basal specimens were fixed in 10% buffered formalin, embedded in paraffin, cut into 4-m-thick sections, and stained with hematoxylin-eosin, Masson's trichrome, and Sirius red F3BA (0.1% solution in saturated aqueous picric acid; Aldrich). Quantitative assessments, including cell size and cell number, were carried out in randomly chosen high-power fields (HPFs) in each section; morphometrical analyses of the areas of the infarct, fibrosis, and immunopositive cells were carried out using a multipurpose color image processor (LUZEX F; Nireco, Kyoto, Japan) as previously described (17) .
Immunohistochemistry
Tissue sections, including 4-m-thick deparaffinized sections and 8-m-thick cryosections from the apical half of the ventricle, were incubated with a primary antibody against BrdU (Zymed), ␣-smooth muscle actin (SMA; 1A4; Sigma), endothelial cells (Flk-1; Santa Cruz), macrophages (Mac3; Biomedicals), leukocytes (CD45/Ly6, 3F11; Pharmingen), T lymphocytes (CD3, 145-2C11; Pharmingen), Akt (Cell Signaling), phosphorylated (Ser 473 ) Akt (p-Akt; Cell Signaling), or insulin-like growth factor (IGF)-I receptor (IGF-IR; Sigma). An ABC kit (Dako) was then used to immunostain the deparaffinized sections; diaminobenzidine served as the chromogen. For immunofluorescence, Alexa Fluor 568 or 488 (Molecular Probes) served as the secondary antibody. Nuclei were counterstained with hematoxylin or Hoechst 33342. The sections were observed under a light microscope or a confocal laser scanning microscope (LSM510; Zeiss). Quantitative assessments, including the number or area of immunopositive cells, were made in 20 randomly chosen HPFs using a multipurpose color image processor.
In situ nick end-labeling (TUNEL) assays were carried out with sections using an ApopTag kit with a biotin-or FITC-labeling kit (Intergene) according to the supplier's instructions. Mouse mammary tissue served as a positive control.
For double-label immunohistochemistry, sections were stained first using anti-BrdU antibody or TUNEL (FITC labeling) as described above, then using a second primary antibody against ␣-SMA or Flk-1 followed by Alexa Fluor 568.
Western Blotting
Proteins (100 g) extracted from whole ventricles were subjected to 14% PAGE and then transferred to polyvinylidene difluoride membranes. The hearts used were collected from three randomly chosen mice of each group. The membranes were then probed using a primary antibody against Akt, p-Akt, or IGF-IR, after which the blots were visualized using enhanced chemiluminescence (Amersham), and the signals were quantified by densitometry. ␣-Tubulin (analyzed using antibody from Sigma) served as the loading control.
Statistical Analysis
Values are shown as means Ϯ SD. Survival was analyzed using the Kaplan-Meier method with the log-rank Cox-Mantel method. The significance of differences between groups was evaluated using t-tests or one-way ANOVA with a post hoc Newman-Keuls multiple-comparison test. Values of P Ͻ 0.05 were considered significant.
RESULTS
Magnitude of Acute Myocardial Infarct
The sizes of acute infarcts were evaluated in WT (n ϭ 8) and AT 1A KO (n ϭ 8) mice killed 2 days after the onset of MI. Histological morphometry in preparations stained with Masson's trichrome showed that the percent LV area taken up by the acute infarct did not significantly differ between WT (40 Ϯ 4.8%) and AT 1A KO [41 Ϯ 3.2%, P ϭ not significant (NS)] mice.
Survival and Cardiac Remodeling and Function 4 wk Post-MI
MI induced in WT without (n ϭ 20) or with (n ϭ 15) hydralazine treatment and AT 1A KO (n ϭ 20) mice was followed up for 4 wk. The survival rate 4 wk post-MI tended to be higher among AT 1A KO (75%) than WT mice without (55%) or those with (60%) hydralazine, although the difference was not significant.
Echocardiography and cardiac catheterization carried out in WT mice, either untreated or hydralazine treated, revealed severe LV remodeling with marked enlargement of the LV cavity and signs of decreased cardiac function 4 wk post-MI, i.e., reduced LV percent fractional shortening, reduced ϮdP/dt, and increased LV end-diastolic pressure (Fig. 1A) . Each of these conditions was significantly moderated in AT 1A KO mice, indicating attenuation of post-MI remodeling and cardiac dysfunction. These data are generally comparable with those reported earlier (11) .
Histopathology of Hearts 4 wk Post-MI
Gross morphometry. Heart-to-body weight ratios were significantly smaller in AT 1A KO (5.4 Ϯ 0.71 mg/g) than in untreated (6.6 Ϯ 0.93 mg/g) or hydralazine-treated (6.3 Ϯ 1.1 mg/g) WT mice 4 wk post-MI. Whereas the hearts of WT mice, either untreated or hydralazine-treated, showed marked LV dilatation with a thin infarcted segment, those of AT 1A KO mice presented substantially small LV cavity and thicker infarcted segment with a shorter circumferential length (Fig. 1, B  and C) . Both the absolute area of the infarct and the percentage of the infarcted area in the LV area were comparable between WT and AT 1A KO mice (%infarct area in LV: 17.2 Ϯ 4.3% in untreated WT, 16.5 Ϯ 5.2% in hydralazine-treated WT, and 17.7 Ϯ 2.8% in AT 1A KO).
Infarcted area. Four weeks post-MI, the infarct area was replaced by fibrous scar tissue in WT mice. In AT 1A KO mice, by contrast, not only collagen fibers but also abundant cellular components were present (Fig. 2, A and B) . The population of noncardiomyocytes within the infarct area was significantly greater; thus, the relative percentage of fibrosis tissue was significantly smaller in AT 1A KO mice (Fig. 2, A and B, and Table 1 ). The number of Flk-1-positive blood vessels present within the infarct areas was also greater in AT 1A KO than WT mice ( Fig. 2C and Table 1 ). In addition, the percent area of extravascular ␣-SMA-positive cells was significantly greater in AT 1A KO mice ( Fig. 2D and Table 1 ), and some of those ␣-SMA-positive cells accumulated to form bundles that were not observed in the infarcted walls of WT mice. Leukocytes, macrophages, and T lymphocytes were rarely observed in either group, and their incidences were similar between WT and AT 1A KO mice (Table 1) .
Noninfarcted area. Consistent with an earlier report, Sirius red staining showed there to be significantly less fibrosis in the noninfarcted LV walls of AT 1A KO than WT hearts (Table 1 ). In addition, the transverse diameters of the cardiomyocytes in the noninfarcted area were significantly greater in WT than AT 1A KO hearts ( Table 1 ), suggesting that compensatory hypertrophy of cardiomyocytes was less developed in the latter. 
Granulation Tissue Cell Dynamics Within Infarct Tissue 1 wk Post-MI
As summarized above, we found larger numbers of cells, especially ␣-SMA-positive and endothelial cells, in the infarcted areas of AT 1A KO hearts 4 wk post-MI. Because we thought that the dynamics of these cells during the ongoing healing process might explain the difference in infarct tissue remodeling seen in WT and AT 1A KO mice 4 wk post-MI, we next evaluated the granulation tissue cell dynamics (apoptosis and cell proliferation) in WT (n ϭ 6) and AT 1A KO (n ϭ 9) hearts 1 wk post-MI.
Apoptosis among granulation tissue cells was detectable in TUNEL assays in both WT and AT 1A KO hearts. The incidence of TUNEL-positive cells was significantly smaller in AT 1A KO hearts (%TUNEL-positive cells: WT, 4.4 Ϯ 0.5% vs. AT 1A KO, 3.3 Ϯ 0.4%, P Ͻ 0.05), whereas BrdU assays showed that granulation tissue cell proliferation was similar (%BrdU-positive cells: WT, 5.2 Ϯ 2.2% vs. AT 1A KO, 6.8 Ϯ 2.5%, P ϭ NS). Double-label immunofluorescense assays (TUNEL followed by Flk-1 or ␣-SMA immunofluorescence) showed that apoptosis occurred among Flk-1-positive endothelial cells (1.7 Ϯ 0.17%) and ␣-SMA-positive smooth muscle cells (17 Ϯ 2.9%) in WT hearts (Fig. 3) . Although apoptosis among them was observed also in AT 1A KO hearts (photographs not shown), the incidence of both TUNEL-positive endothelial cells (1.1 Ϯ 0.12%) and TUNEL-positive smooth muscle cells (9.8 Ϯ 1.2%) was significantly less frequent compared with that in WT hearts. In addition, similar assays in which BrdU staining was followed by Flk-1 or ␣-SMA staining revealed proliferation of Flk-1-positive vessels within granulation tissue to be significantly greater in AT 1A KO (%BrdU, 4.5 Ϯ 0.36%) than WT hearts (%BrdU, 3.2 Ϯ 0.40%, P Ͻ 0.05), whereas proliferation of ␣-SMA-positive cells was similar (%BrdU, 12 Ϯ 2.6% in AT 1A KO vs. 8.9 Ϯ 2.1% in WT, On the other hand, TUNEL-positive cardiomyocytes were extremely rare (0.0083 Ϯ 0.020% in WT vs. 0.0078 Ϯ 0.017% in AT 1A KO, P ϭ NS), and no BrdU-positive cardiomyocytes were detected in either group 1 wk post-MI.
Molecular Signaling Within Infarct Tissue 1 Wk Post-MI
Our finding that granulation tissue cells were prone to proliferation and resistant to apoptosis in AT 1A KO hearts prompted us to investigate the involvement of several known molecular mediators. Both the IGF and renin-angiotensin systems are activated following MI. In that regard, the IGF-IR, which mediates the effects of IGF-I and growth hormone, is upregulated following MI and is thought to exert a beneficial effect on post-MI cardiac remodeling (4, 18). Akt is a major signaling molecule downstream of the IGF-IR (21) . We found that the protein levels of IGF-IR, Akt, and p-Akt were all increased in hearts 1 wk post-MI and that the magnitude of the increase was greater in AT 1A KO than WT mice (Fig. 4A) . Moreover, immunohistochemical assays revealed that both IGF-IR and Akt were predominantly localized in granulation tissue cells, including vascular endothelial cells within the infarcted area (Fig. 4B) .
We next administered wortmannin, a widely used PI 3-kinase/Akt inhibitor, to AT 1A KO mice with MI to further elucidate the role for Akt signaling in infarct dynamics, LV remod- eling, and function. Treatment with wortmannin was confirmed to prevent the increase in Akt activity observed in AT 1A KO hearts 1 wk post-MI (Fig. 5A) . It was also found to restore the decreased apoptosis in granulation tissue cells (Fig. 5B) . Importantly, treatment with wortmannin partially but significantly reversed the attenuated post-MI remodeling and dysfunction at the chronic stage (Fig. 5C) . Overall, these findings suggest a significant involvement of increased activity of Akt signaling in post-MI benefits properly observed in AT 1A KO mice.
DISCUSSION
AT 1A -Dependent Alteration of Infarct Tissue Structure
Myocardial fibrosis leads to both systolic and diastolic dysfunction in the heart (2), and it is well known that AT 1 signaling unfavorably affects post-MI heart function by inducing excessive fibrosis in noninfarcted heart tissue (12, 26, 29) . The effect of AT 1A signaling on the infarct scar had not been well characterized, however. The present study clearly demonstrates AT 1A -dependent differences in infarct scar structure in the absence of changes in the absolute area of infarct; the infarcted segment was thicker and had a smaller circumferential length in AT 1A KO than WT hearts 4 wk post-MI. It is clear that these benefits on post-MI cardiac function and remodeling observed in AT 1A KO were independent of the blood pressurelowering effect when compared with the hydralazine-treated group. However, it should be noted that this idea might not hold true for the case with abnormally high pressure overload in which mechanisms for damaging the heart are too complicated to be explained simply by AT 1 signaling. For instance, Harada et al. (11) reported that AT 1A KO mice still develop cardiac hypertrophy in response to increased blood pressure. Significantly preserved cell components in scar tissue of AT 1A KO were likely to responsible for the infarct wall thickening. Abundant ␣-SMA-positive myofibroblasts in the infarct segment, which are well known to be important for wound shrinkage by their contractile property (9), would have contributed to suppression of infarct expansion and also ventricular dilatation and aneurysm formation. Progressive ventricular wall thinning and chamber dilation are associated with increased incidence of congestive heart failure, aneurysm formation, and mortality (23) . Wall stress is proportional to the cavity diameter and inversely proportional to the wall thickness (Laplace's law; see Ref. 40) , and wall stress and ventricular remodeling (dilatation) have a vicious relationship accelerating each other. Therefore, it is conceivable that such an alteration of infarct scar structure would bring a marked benefit in improving hemodynamic state. In addition, the preservation of vessels might relieve ischemia of the surviving tissue.
Effect of AT 1A on Granulation Tissue Cell Dynamics and Its Mechanism
The present study also demonstrates that infarct scar tissue is qualitatively altered by AT 1A signaling. We observed higher numbers of cells, including abundant myofibroblasts and endothelial cells, in the old infarcted area of AT 1A KO hearts. Both myofibroblasts and endothelial cells disappear via apoptosis along the natural healing course (6, 31) . We found that apoptosis among those cells was significantly suppressed in AT 1A KO hearts 1 wk post-MI, which implies that AT 1A signaling exerts a proapoptotic effect on myofibroblasts and endothelial cells in WT hearts. This likely reflects the fact that ANG II acts, at least in part, via AT 1A to stimulate production of transforming growth factor-␤1 (12, 16, 29) , which in turn increases the susceptibility of some cell types, including lung epithelial cells (10) and granulation tissue cells following MI (22) , to Fas-induced apoptosis. Taken together, our findings suggest that, in AT 1A KO hearts, myofibroblasts that escape apoptotic death during the subacute stage (granulation tissue phase) of MI survive until the chronic stage (scar phase) and might contribute to infarct contraction and increase infarct wall thickness. That, in turn, would alter infarct tissue structure, reducing wall stress and mitigating LV dilatation and dysfunction. These finding are entirely comparable with the notion that inhibition of granulation tissue cell apoptosis is therapeutic, as evidenced by our previous study using a pancaspase inhibitor to subacute MI (13) . The small difference in the incidence of granulation tissue cell apoptosis (1.1%) between WT (4.4 Ϯ 0.5%) and AT 1A KO (3.3 Ϯ 0.4%) may seem not to have any major physiological meaning. However, the apoptotic process finishes within hours (7) and thus the time interval of expressing TUNEL positivity in cells is considered relatively short. Moreover, Wencker et al. (38) reported that the difference of only 0.0215% in the incidence of TUNEL assay caused heart failure in transgenic mice expressing a conditionally active caspase exclusively in the myocardium (%TUNEL ϭ 0.023%) despite no heart failure in controls (%TUNEL ϭ 0.0015%). This may justify the difference of 1.1% in apoptosis in the present study to be significant enough to have a physiological meaning.
Akt is an angiogenic and survival factor (14) and is a major signaling molecule downstream of the IGF-IR. ANG II was recently reported to inhibit insulin-and IGF-I-induced Akt activation in vascular smooth muscle and endothelial cells (1, 20) . The present study confirms that protein levels of both IGF-IR and p-Akt are increased in hearts 1 wk post-MI and that the increase was more pronounced in AT 1A KO than WT hearts. Moreover, we have shown that Akt signal inhibition partially but significantly prevented the favorable post-MI process observed in AT 1A KO mice, which was accompanied by increased apoptosis of granulation tissue cells. This may suggest that, in AT 1A KO hearts, the absence of AT 1A signaling exerts an enhanced proliferative and antiapoptotic effect via, at least in part, Akt activation on granulation tissue cells. However, signals other than Akt activation should be considered to be involved, which contributed to the benefits observed in AT 1A KO, because the Akt inhibition worked only partially. In addition, Akt inhibition did not suppress granulation tissue cell apoptosis in WT although it did in AT 1A KO, perhaps more strongly suggesting involvement of other factors.
Discrepancies have occurred among studies of the effects of ANG II/AT 1 or AT 1A on vascularization. For instance, Sasaki et al. (25) showed that ANG II/AT 1 induces neovascularization in ischemic legs, whereas Fabre et al. (8) reported that ACE inhibition stimulates neovascularization, which is consistent with our findings. Also consistent with our findings are the reports of Walther et al. (34) , who showed that AT 1 inhibits angiogenesis in a mouse alginate implant angiogenesis model, and de Boer et al. (5), who showed that post-MI microvessel density is reduced in transgenic rats overexpressing AT 1 in the heart and that the reduction in microvessel density is reversed by the AT 1 blocker losartan. Very recently, Wang et al. (35) have shown by a new technique that losartan significantly restored vascular perfusion in a 4-wk-old infarct scar in rat hearts and suggested AT 1 as being antiangiogenic. The difference may partly result from the fact that the effect on angiogenesis is strongly dependent on the model. Therefore, the data on angiogenesis must be carefully reviewed based on the experimental model, animal, and pharmacological treatment. Nevertheless, our findings are apparently at variance with those of Toko et al. (32) , who reported that vascularization in 2-wk-old infarcts in AT 1A KO hearts was sparcer than in WT hearts. Although the notion that neovascularization after MI beneficially affects post-MI cardiac function seems to support our findings, further investigations are warranted to clarify the facts.
In conclusion, the present findings suggest that, in addition to inducing fibrosis in noninfarcted areas, AT 1A signaling exerts an effect on infarct tissue dynamics, i.e., it alters infarct scar structure and histology by accelerating apoptosis and/or decelerating proliferation of endothelial cells and ␣-SMApositive myofibroblasts in granulation tissue. These may provide a new mechanistic insight into deleterious effects of AT 1A signaling on the post-MI heart, although the relative importance of the present mechanism, compared with the previously shown antifibrotic mechanism, on the post-MI LV remodeling and dysfunction has not been elucidated. Further investigations are warranted.
